Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer | NEJM

Correspondence from The New England Journal of Medicine — Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

Read the full article here

Related Articles